Emergence of Coronary Heart Disease as a Diagnosis | p. 1 |
In Osler's Textbook (1904) | p. 1 |
First Reports of Coronary Thrombosis with Survival | p. 2 |
Papers Appear in British Journals | p. 3 |
Added to International List of Causes of Death (1930) | p. 4 |
Experimental Pathology in St. Petersburg | p. 5 |
Atherosclerosis Introduced as a Pathological Term | p. 5 |
Pioneering Experimental Work 1908-1913 Feeding Cholesterol to Rabbits in St. Petersburg | p. 5 |
Anitschkow Described His Work Further in 1933 American Monograph | p. 6 |
Anitschkow's Early Rabbit Work Confirmed in Other Countries | p. 7 |
Rabbits' Arterial Lesions Compared with Human Atherosclerosis | p. 7 |
Is Plasma Cholesterol Raised with Human Atherosclerosis? | p. 9 |
Cholesterol Characteristic in Human Atherosclerosis | p. 9 |
At First not Clear if Plasma Cholesterol Raised with Human Atherosclerosis | p. 9 |
Improved Statistical Design Shows Average Plasma Cholesterol Higher with CHD | p. 10 |
It is Low-Density Lipoproteins that are Associated with CHD | p. 10 |
"Normal" Cholesterol Level in Affluent Countries May not be Healthy Cholesterol | p. 11 |
Serum Cholesterols Lower in Naples and Madrid and Hunter Gatherers | p. 11 |
Diet can have Worth while Effects on Human Plasma Cholesterol | p. 13 |
Dietary Cholesterol | p. 13 |
Dietary Fat has more Effect than Dietary Cholesterol | p. 14 |
And the Type of Dietary Fat | p. 14 |
Saturated and Polyunsaturated Fats, Rather than Animal or Vegetable Fats | p. 14 |
Repeated Tests by Keys' Group with Different Fats and Oils | p. 16 |
Not all Saturated Fatty Acids have the same Effect on Serum Cholesterol | p. 17 |
How does it Work? Could it be by Changing Cholesterol Excretion? | p. 18 |
Discovery of the Low Density Lipoprotein Receptor | p. 18 |
A New Type of Observational Epidemiology | p. 21 |
Invention of Prospective, Cohort Studies | p. 21 |
The Framingham Study, Started 1949 | p. 21 |
Results Emerge from Framingham and Subsequent Cohort Studies | p. 22 |
Big Three Risk Factors: Serum Cholesterol, Smoking and Blood Pressure | p. 22 |
Tentative Recommendations to High Risk Patients Start in 1960s | p. 23 |
Serum Triglycerides? Another Risk Factor | p. 25 |
Endogenous and Exogenous Serum Triglycerides | p. 25 |
Early Claims that Serum Triglycerides Predict Risk of CHD | p. 25 |
Fasting Serum Triglycerides not a Strong Independent Risk Factor | p. 26 |
Fredrickson's Classification of the Hyperlipoproteinaemias | p. 29 |
Five Types of Hyperlipidaemia, and Three Types of Low Serum Lipoproteins | p. 29 |
Further Developments of Fredrickson's Types | p. 31 |
The Seven Countries Study (7CS) | p. 33 |
Setting Up | p. 33 |
Methods | p. 35 |
Results | p. 35 |
Dietary Results | p. 36 |
Implications from the 7CS | p. 37 |
Longer Follow Up | p. 38 |
Sucrose - An Alternative Dietary Hypothesis | p. 39 |
Yudkin's Proposal | p. 39 |
Reactions | p. 40 |
HDL-Cholesterol is Protective | p. 41 |
Early Observations | p. 41 |
The Millers' Hypothesis | p. 42 |
It Ran Against the Grain | p. 42 |
Epidemiological Support | p. 42 |
HDL2 or HDL3? | p. 43 |
In Developing Countries? | p. 43 |
In Women | p. 43 |
Diet Affects HDL-Cholesterol Quite Differently | p. 44 |
Critics and Sceptics | p. 45 |
Sir John McMichael, London | p. 45 |
Dr George Mann, USA | p. 46 |
Thrombosis on and in Atheroma | p. 49 |
Thrombosis a Separate, Acute Process | p. 49 |
Tests for Liability to Thrombosis are Indirect | p. 49 |
Or can Mural Thrombosis Become Atheroma? | p. 50 |
Dietary Cholesterol May Affect Plasma Cholesterol | p. 51 |
Keys had Asserted Dietary Cholesterol does not Raise Plasma Cholesterol | p. 51 |
Other Early Studies Inconclusive | p. 51 |
Keys' Group and Hegsted's Group Re-examine | p. 52 |
Metabolism of Labelled Cholesterol | p. 52 |
Many Human Experiments with Dietary Cholesterol 1960s and 1970s | p. 53 |
Are some Individuals Responsive to Dietary Cholesterol, not Others? | p. 54 |
Effect of Basal Cholesterol Intake | p. 55 |
Different Recommendations by Advisory Committes | p. 56 |
First Controlled Trials | p. 57 |
First Two Randomised Dietary Trials, 1965 | p. 57 |
Two more Dietary Trials | p. 58 |
The Los Angeles VA Trial, Reported 1969 | p. 59 |
Helsinkin Mental Hospitals | p. 59 |
Drugs Trials | p. 61 |
Early Trials with Cholesterol-Lowering Drugs | p. 61 |
More Promising Drugs Followed | p. 61 |
"Atromid" or Clofibrate | p. 62 |
Cholestyramine Resin | p. 62 |
Dietary Fibre | p. 63 |
Obesity | p. 65 |
Desirable Weight for Height | p. 65 |
Body Mass Index | p. 66 |
Waist Circumference - Visceral Adiposity | p. 69 |
At the End of the Century the Cardiac Risk of Overweight Remained Variable for Moderate Overweight | p. 70 |
Thrombosis Treated Early | p. 71 |
Acute Phase Coronary Angiography | p. 71 |
Clotting Factors in a Prospective Study | p. 72 |
Platelet Function | p. 73 |
What's a Normal Plasma Cholesterol? | p. 74 |
Fish Oil | p. 77 |
Traditional Eskimos: High Fat Diet but CHD Uncommon | p. 77 |
Eicosapentaenoic Acid Reduces Platelet Aggregation | p. 78 |
Epidemiological Studies: Fish Consumption and CHD | p. 79 |
Polyunsaturated Oils Prevent Dangerous Arrhythmias in Rats | p. 80 |
Human Prevention Trials with Fish Oil | p. 81 |
Alcohol | p. 83 |
Impressions at Post-mortem Examination | p. 83 |
Negative Association with CHD in 1974 Case-Control Study | p. 84 |
Epidemiological Studies Build Up the Case | p. 84 |
Alcohol Only Benefits Health of Older People in Developed Countries | p. 86 |
Which Type of Alcoholic Drink? | p. 87 |
How does Alcohol Reduce the Risk of CHD? | p. 88 |
Serum HDL-Cholesterol (HDL-c) | p. 88 |
Haemostatic Effects | p. 89 |
Polyphenolic Antioxidants in the Beverage | p. 89 |
The French Paradox | p. 89 |
Coffee | p. 91 |
Coffee and Caffeine | p. 91 |
Coffee and CHD (Direct) Epidemiology | p. 92 |
Coffee and Serum Cholesterol: Human Experiments | p. 93 |
It's Cafestol and Kahweol in Coffee that Raise Serum Cholesterol | p. 94 |
And Tea? | p. 95 |
Trans-Fatty Acids | p. 97 |
Hydrogenation of Liquid Oils to make Solid Margarines | p. 97 |
Human Experiments: Trans Fatty Acids and Serum Cholesterol | p. 98 |
Epidemiological Studies | p. 101 |
Conclusion | p. 102 |
Antioxidants | p. 103 |
LDL Oxidation and Atherosclerosis - Hypothesis | p. 103 |
¿-Tocopherol the Major Antioxidant Inside LDL | p. 104 |
Vitamin E and CHD in Cohort Studies | p. 104 |
Randomised Controlled Prevention Trials with Vitamin E | p. 105 |
Trials with Beta-Carotene | p. 105 |
Why didn't Alpha Tocopherol or Beta Carotene Work? | p. 106 |
Fruit and Vegetables - Part of Favourable Dietary Patterns | p. 106 |
More Controlled Dietary Trials | p. 109 |
Further Dietary Trials in Table 23.1 | p. 109 |
Two Large Multi-Factorial Trials | p. 112 |
Four Dietary Trials Assessed by Coronary Angiography | p. 113 |
The Lyon Diet Heart Study | p. 114 |
Trials of Better Drugs | p. 115 |
Cholestyramine (1984) | p. 115 |
Gemfibrozil (1987) | p. 116 |
Statins Arrive | p. 116 |
Implications of Statins | p. 118 |
Linoleic Acid is Protective | p. 121 |
Cohort Studies Accumulate | p. 121 |
Mechanism(s) of Action | p. 123 |
Linoleic (18:2) not the Usual Source of Arachidonic Acid (20:4) | p. 123 |
Recommendations | p. 123 |
Plant Sterols Fade and Return | p. 125 |
Phytosterols not Absorbed | p. 125 |
The Pharmaceutical Phase | p. 126 |
Sitosterolaemia | p. 127 |
The Food Additive Phase | p. 127 |
Soy Proteins Versus Casein | p. 129 |
An Animal Protein Effect on Serum Cholesterol in Rabbits | p. 129 |
In Humans Soy Protein Compared Against Casein: Variable Results | p. 130 |
Isoflavones may Contribute | p. 131 |
High Homocysteine Associated with Cardiovascular Diseases | p. 133 |
Homocystinuria and Arterial Disease | p. 133 |
Raised Plasma Homocysteine and Arterial Disease | p. 134 |
Environmental Influences on Plasma Homocysteine | p. 135 |
Plasma Homocysteine Lowered by Folic Acid and/or Vitamin B-12 | p. 136 |
And Salt should be Included | p. 139 |
Discovery of Essential Hypertension | p. 139 |
Early Diets for Hypertension | p. 140 |
Is Salt a Cause of Essential Hypertension? | p. 142 |
Thiazides and Sceptics | p. 144 |
Potassium and Blood Pressure | p. 144 |
Answers to the Sceptics; the Salt Case Develops | p. 145 |
Moderate Sodium Restriction | p. 145 |
Remote Communities | p. 146 |
Regression Dilution Bias | p. 147 |
Intersalt | p. 147 |
Chimpanzee Experiments | p. 148 |
Cardiac Effects of Salt Reduction | p. 149 |
Higher Blood Pressures in African Americans | p. 149 |
Baby Food Manufacturers take the Lead | p. 150 |
And for Adults | p. 151 |
Dietary Goals for the US | p. 151 |
Subsequent Official Recommendations | p. 152 |
Most Salt we Eat was Put in by Food Processors | p. 152 |
How does BP Increase in Salt-Sensitive Individuals | p. 153 |
Kidneys | p. 153 |
Arterioles | p. 153 |
Humoral Inhibitor of the Sodium Pump | p. 154 |
Into the Next Century | p. 155 |
How it Adds Up | p. 157 |
American Heart Association, 2000 | p. 157 |
In "ABC of Nutrition", 1999 | p. 158 |
The Big Picture | p. 161 |
USA and Canada | p. 161 |
Australia and New Zealand (Fig. 31.4) | p. 164 |
Nordic Countries | p. 166 |
British Isles (Fig. 31.6) | p. 167 |
Western Europe | p. 168 |
East European Countries | p. 169 |
End Notes | p. 173 |
What Happened | p. 173 |
On the Research Front | p. 174 |
Inertia and Opposition | p. 175 |
In the Public Arena | p. 176 |
What Happened Further | p. 177 |
Hypothesis and Variations | p. 178 |
References | p. 181 |
Index | p. 221 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.